3-thioxo-5,6,7,8-tetrahydro-1H,2H-benzo[4,5]thieno[2,3-d][1,2,4]triazolo[4,5-a]-pyrimidin-5-one | 245362-41-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三唑并嘧啶类
• 英文名称: 3-thioxo-5,6,7,8-tetrahydro-1H,2H-benzo[4,5]thieno[2,3-d][1,2,4]triazolo[4,5-a]-pyrimidin-5-one
• 英文别名: 14-Sulfanylidene-8-thia-10,12,13,15-tetrazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2(7),10-trien-16-one
• CAS: 245362-41-8
• 化学式: C₁₁H₁₀N₄OS₂
• 分子量: 278.359
• InChiKey: ROKQLRXCDQMKTQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  18
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  117
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  二硫化碳 、 2-hydrazino-5,6,7,8-tetrahydro<1>benzothieno<2,3-d>pyrimidin-4(3H)-one 在 吡啶 作用下， 反应 5.0h， 以81%的产率得到3-thioxo-5,6,7,8-tetrahydro-1H,2H-benzo[4,5]thieno[2,3-d][1,2,4]triazolo[4,5-a]-pyrimidin-5-one
  参考文献：
  名称：

  一些新型噻吩并[2,3-d]嘧啶的合成、表征和生物学研究

  摘要：

  已经从 2-氨基噻吩-3-羧酸酯及其腈类似物制备了几种 2-未取代的噻吩并 [2,3-d] 嘧啶。一些三唑并噻吩并嘧啶和 2-硫代噻吩并嘧啶的代表也已使用热和微波 (MW) 辐射技术合成。基于红外、核磁共振、二维核磁共振和质谱数据阐明了所制备化合物的结构。还检查了一些选定的合成化合物的生物活性。

  DOI：

  10.3390/molecules15063932

文献信息

• Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
  申请人：——

  公开号：US20040171603A1

  公开（公告）日：2004-09-02

  Described herein is the discovery that certain mycobacterial serine/threonine protein kinases, particularly protein kinase G (PknG), are effective therapeutic targets for the treatment of mycobacterial infections. Furthermore, the present application refers to the use of mycobacterial serine/threonine protein kinases for developing methods for detection and determination of these kinases for recognizing and monitoring diseases and for controlling therapy of diseases. Additionally disclosed are novel 4,5,6,7-tetrahydrobenzo[b]thiophene compounds, benzo(g)quinoxaline compounds, and pharmaceutically acceptable salts thereof, and methods of using such compounds and salts thereof for the prophylaxis and/or treatment of virally and/or bacterially induced infections, particularly mycobacteria-induced infections, including opportunistic infections, as well as pharmaceutical compositions containing at least one 4,5,6,7-tetrahydrobenzo[b]thiophene compound and/or benzo(g)quinoxaline compound and/or pharmaceutically acceptable salts thereof in a pharmaceutically acceptable carrier.

  本文描述的是发现某些分枝杆菌丝氨酸/苏氨酸蛋白激酶，特别是蛋白激酶 G (PknG)，是治疗分枝杆菌感染的有效治疗靶点。此外，本申请还涉及利用分枝杆菌丝氨酸/苏氨酸蛋白激酶开发检测和测定这些激酶的方法，用于识别和监测疾病以及控制疾病的治疗。此外，还公开了新型 4,5,6,7-四氢苯并[b]噻吩化合物、苯并（g）喹喔啉化合物及其药学上可接受的盐，以及使用此类化合物及其盐预防和/或治疗病毒和/或细菌引起的感染，特别是分枝杆菌引起的感染（包括机会性感染）的方法，以及含有至少一种 4,5,6,7-四氢苯并&lsqb；b]噻吩化合物和/或苯并(g)喹喔啉化合物和/或其药学上可接受的盐，并将其置于药学上可接受的载体中。
• 4,5,6,7-TRETRAHYDROBENZO(B) THIOPHENE DERIVATIVES AND METHODS FOR MEDICAL INTERVENTION AGAINST MYCROBACTERIAL INFECTIONS
  申请人：Axxima Pharmaceuticals AG

  公开号：EP1492783A1

  公开（公告）日：2005-01-05
• 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and methods for medical intervention against mycobacterial infections
  申请人：Missio Andrea

  公开号：US20090018149A1

  公开（公告）日：2009-01-15

  Described are 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and pharmaceutically acceptable salts thereof, the use of these derivatives for the prophylaxis and/or treatment of mycobacteria-induced infections and opportunistic infections, as well as compositions containing at least one 4,5,6,7-tetrahydrobenzo[b]thiophene derivative and/or pharmaceutically acceptable salts thereof. Furthermore, the present application refers to the use of mycobacterial protein serine/threonine kinases for developing methods for detection and determination of these kinases for recognising and monitoring diseases and for controlling therapy of diseases.
• [EN] 4,5,6,7-TRETRAHYDROBENZO[B] THIOPHENE DERIVATIVES AND METHODS FOR MEDICAL INTERVENTION AGAINST MYCROBACTERIAL INFECTIONS<br/>[FR] DERIVES DE 4,5,6,7-TETRAHYDROBENZO[B]THIOPHENE ET METHODES D'INTERVENTION MEDICALE CONTRE LES INFECTIONS MYCOBACTERIENNES
  申请人：AXXIMA PHARMACEUTICALS AG

  公开号：WO2003084947A1

  公开（公告）日：2003-10-16

  Described are 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and pharmaceutically acceptable salts thereof, the use of these derivatives for the prophylaxis and/or treatment of mycobacteria-induced infections and opportunistic infections, as well as compositions containing at least one 4,5,6,7-tetrahydrobenzo[b]thiophene derivative and/or pharmaceutically acceptable salts thereof. Furthermore, the present developing methods for detection and determination of these kinases for recognising and monitoring diseases and for controlling therapy of diseases.
• Synthesis, Characterization and Biological Studies of Some Novel Thieno[2,3-d]pyrimidines
  作者：Khulud M. Al-Taisan、Hassan M. A. Al-Hazimi、Shar S. Al-Shihry

  DOI：10.3390/molecules15063932

  日期：——

  Several 2-unsubstituted thieno[2,3-d]pyrimidines have been prepared from 2-aminothiophene-3-carboxylic acid esters and their carbonitrile analogs. Some triazolo-thienopyrimidine and 2-thioxothienopyrimidine representatives have also been synthesized using thermal and microwave (MW) irradiation techniques. Structures of the prepared compounds were elucidated on the basis of IR, NMR, 2D NMR and mass

  已经从 2-氨基噻吩-3-羧酸酯及其腈类似物制备了几种 2-未取代的噻吩并 [2,3-d] 嘧啶。一些三唑并噻吩并嘧啶和 2-硫代噻吩并嘧啶的代表也已使用热和微波 (MW) 辐射技术合成。基于红外、核磁共振、二维核磁共振和质谱数据阐明了所制备化合物的结构。还检查了一些选定的合成化合物的生物活性。